Isfahan University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share this content! On (X network) By
Association of Rasis and Hmg-Coa Reductase Inhibitors With Clinical Manifestations in Coronavirus Disease 2019 Patients: Results From the Khorshid Coronavirus Disease Cohort Study Publisher



Iraj B1 ; Moravejolahkami AR2 ; Sami R3 ; Riahinezhad M4 ; Tasdighi Z5 ; Toghyani A1 ; Hosseini NS1 ; Niri FD1 ; Askari G6
Authors
Show Affiliations
Authors Affiliations
  1. 1. Department of Internal Medicine, School of Medicine, Endocrine and Metabolism Research Center, Isfahan University of Medical Sciences, Isfahan, Iran
  2. 2. Department of Clinical Nutrition, School of Nutrition & Food Science, Isfahan University of Medical Sciences, Isfahan, Iran
  3. 3. Department of Internal Medicine, School of Medicine, Khorshid Hospital, Isfahan University of Medical Sciences, Isfahan, Iran
  4. 4. Department of Radiology, Isfahan University of Medical Science, Isfahan, Iran
  5. 5. Department of Epidemiology and Biostatistics, School of Health, Isfahan University of Medical Sciences, Isfahan, Iran
  6. 6. Department of Community Nutrition, School of Nutrition and Food Science, Isfahan University of Medical Sciences, Isfahan, Iran

Source: Journal of Research in Medical Sciences Published:2023


Abstract

Background: Angiotensin II receptor blockers (ARBs) and angiotensin-converting enzyme inhibitors (ACEinhs) may deteriorate or improve the clinical manifestations in severe acute respiratory syndrome coronavirus 2 infection. A comparative, cross-sectional study was conducted to evaluate the association of ARBs/ACEinhs and hydroxy-3-methyl-glutaryl-CoA reductase inhibitors (HMGRis) with clinical outcomes in coronavirus disease 2019 (COVID-19). Materials and Methods: From April 4 to June 2, 2020, 659 patients were categorized according to whether they were taking ARB, ACEinh, or HMGRi drugs or none of them. Demographic variables, clinical and laboratory tests, chest computed tomography findings, and intensive care unit-related data were analyzed and compared between the groups. Results: The ARB, ACEinh, and HMGRi groups significantly had lower heart rate (P < 0.05). Furthermore, a lower percent of O2 saturation (89.34 ± 7.17% vs. 84.25 ± 7.00%; P = 0.04) was observed in the ACEis group than non-ACEinhs. Mortality rate and the number of intubated patients were lower in patients taking ARBs, ACEinhs, and HMGRis, although these differences failed to reach statistical significance. Conclusion: Our findings present clinical data on the association between ARBs, ACEinhs, and HMGRis and outcomes in hospitalized, hypertensive COVID-19 patients, implying that ARBs/ACEinhs are not associated with the severity or mortality of COVID-19 in such patients. © 2023 Journal of Research in Medical Sciences.
Related Docs
View other Related Docs
1. Gastrointestinal and Kidney Manifestations in Sarscov and Sars-Cov-2 Infections: Role of Angiotensin-Converting Enzyme 2, Physiology and Pharmacology (Iran) (2021)
2. In Silico Investigation of Critical Binding Pattern in Sars-Cov-2 Spike Protein With Angiotensin-Converting Enzyme 2, Scientific Reports (2021)
3. Mechanisms of Covid-19 Entry Into the Cell: Potential Therapeutic Approaches Based on Virus Entry Inhibition in Covid-19 Patients With Underlying Diseases, Iranian journal of allergy, asthma, and immunology (2021)
4. The Clinical Manifestation and Outcome of Covid-19 in Patients With a History of Ischemic Heart Disease; a Retrospective Case-Control Study, BMC Cardiovascular Disorders (2023)
5. Mesenchymal Stem Cells: A Potent Cell Source for Covid-19, Coronaviruses (2021)
6. Sars-Cov-2, Sars and Mers: Three Formidable Coronaviruses Which Have Originated From Bats; [Sars-Cov-2, Sars-Cov I Mers-Cov: Trzy Grozne Koronawirusy Pochodzace Od Nietoperzy], Postepy Higieny i Medycyny Doswiadczalnej (2021)
7. N-Acetylcysteine and Coronavirus Disease 2019: May It Work As a Beneficial Preventive and Adjuvant Therapy? a Comprehensive Review Study, Journal of Research in Medical Sciences (2020)
8. Risk Factors Associated With Intensive Care Unit (Icu) Admission and In-Hospital Death Among Adults Hospitalized With Covid-19: A Two-Center Retrospective Observational Study in Tertiary Care Hospitals, Emergency Radiology (2021)
Experts (# of related papers)
View all Related Experts
Ramin Sami (8)
Azin Shayganfar (7)
Other Related Docs
9. Severity of Disease and Covid-19 Complications During Hospital Stay: A Prospective Cohort Study, Archives of Iranian Medicine (2022)
10. Angiotensin-Converting-Enzyme Inhibitors (Ace Inhibitors) and Angiotensin Ii Receptor Blocker (Arb) Use in Covid-19 Prevention or Treatment: A Paradox, Infection Control and Hospital Epidemiology (2021)
11. Cancer Care Management During the Covid-19 Pandemic, Risk Management and Healthcare Policy (2020)
12. A One-Year Hospital-Based Prospective Covid- 19 Open-Cohort in the Eastern Mediterranean Region: The Khorshid Covid Cohort (Kcc) Study, PLoS ONE (2020)
13. Model Prediction for In-Hospital Mortality in Patients With Covid-19: A Case–Control Study in Isfahan, Iran, American Journal of Tropical Medicine and Hygiene (2021)
14. Covid-19 Pandemic: Insights Into Genetic Susceptibility to Sars-Cov-2 and Host Genes Implications on Virus Spread, Disease Severity and Outcomes, Human Antibodies (2022)
15. Chest Computed Tomography Severity Score to Predict Adverse Outcomes of Patients With Covid-19, Infection and Chemotherapy (2021)
16. Therapeutic Targets of Natural Products for the Management of Cardiovascular Symptoms of Coronavirus Disease 2019, Phytotherapy Research (2021)
17. Epidemiology, Virology, Clinical Features, Diagnosis, and Treatment of Sars-Cov-2 Infection, Journal of Experimental and Clinical Medicine (Turkey) (2021)
18. Drug Repositioning Approach to Target Viral and Host Cells in Terms of Covid-19 Treatment: A Review of in Vivo Experiments and Clinical Studies, Journal of Experimental and Clinical Medicine (Turkey) (2022)
19. Pi3k/Akt/Mtor Pathway: A Potential Target for Anti-Sars-Cov-2 Therapy, Immunologic Research (2022)
20. Thymus Vulgaris, a Natural Pharmacy Against Covid-19: A Molecular Review, Journal of Herbal Medicine (2023)
21. Two-Step Machine Learning to Diagnose and Predict Involvement of Lungs in Covid-19 and Pneumonia Using Ct Radiomics, Computers in Biology and Medicine (2022)
22. A Study on the Effect of Aspirin on Clinical Symptoms, Laboratory Indices, and Outcomes in Patients With Covid-19, Journal of Nephropharmacology (2023)
23. A Review on the Diagnostic Approaches of Covid-19 Infection; Features and Limitations, Journal of Isfahan Medical School (2021)
24. Age-Dependent Clinical Features and Prognosis of Covid-19 Patients, Tanaffos (2021)
25. Pulmonary Function, Anxiety, Depression, and Sleep Quality After Recovery From Covid-19, Tanaffos (2023)
26. Lactate Dehydrogenase to Albumin Ratio As a Predictive Factor of Covid-19 Patients’ Outcome; a Cross-Sectional Study, Archives of Academic Emergency Medicine (2022)
27. Sars-Cov-2 (Covid-19): New Discoveries and Current Challenges, Applied Sciences (Switzerland) (2020)
28. The Value of Thoracic Computed Tomography Scan Comparing to Reverse Transcription-Polymerase Chain Reaction for the Diagnosis of Covid-19, Journal of Research in Medical Sciences (2021)
29. Using in Silico Bioinformatics Algorithms for the Accurate Prediction of the Impact of Spike Protein Mutations on the Pathogenicity, Stability, and Functionality of the Sars-Cov-2 Virus and Analysis of Potential Therapeutic Targets, Biochemical Genetics (2023)
30. Prevention of Covid-19: Preventive Strategies for General Population, Healthcare Setting, and Various Professions, Advances in Experimental Medicine and Biology (2021)
31. The Potential Effect of Royal Jelly on Biomarkers Related to Covid-19 Infection and Severe Progression, Advances in Experimental Medicine and Biology (2023)
32. Covid-19 Pneumonia: A Pictorial Review of Ct Findings and Differential Diagnosis, Egyptian Journal of Radiology and Nuclear Medicine (2021)
33. Covid-19 and Mers: Are Their Chest X-Ray and Computed Tomography Scanning Signs Related?, Journal of Medical Signals and Sensors (2022)
34. Diagnostic Accuracy and Prognostic Value of Lung Ultrasound in Coronavirus Disease (Covid-19), Polish Journal of Radiology (2022)
35. A Mini-Review on Cardiovascular and Hematological Complications of Covid-19, Coronaviruses (2021)
36. Evaluation of Angiotensin Converting Enzyme 2 (Ace2), Angiotensin Ii (Ang Ii), Mir-141-3P, and Mir-421 Levels in Sars-Cov-2 Patients: A Case-Control Study, BMC Infectious Diseases (2024)
37. Emerging Technologies for the Treatment of Covid-19, Advances in Experimental Medicine and Biology (2021)
38. Clinical Display, Diagnostics and Genetic Implication of Novel Coronavirus (Covid-19) Epidemic, European Review for Medical and Pharmacological Sciences (2020)
39. The Role of N-Acetyl Cysteine and Some Other Clinical Antidotes in the Treatment of Patients With Covid-19; Review of the Current Evidence, Immunopathologia Persa (2023)
40. Tnf-Α Blockers Showed Prophylactic Effects in Preventing Covid-19 in Patients With Rheumatoid Arthritis and Seronegative Spondyloarthropathies: A Case–Control Study, Rheumatology and Therapy (2021)
41. Cytokines and Micrornas in Sars-Cov-2: What Do We Know?, Molecular Therapy Nucleic Acids (2022)
42. Potential Inhibitors of Sars-Cov-2: Recent Advances, Journal of Drug Targeting (2021)
43. Findings of Computed Tomogheraphy Scan Imaging in Patients With Covid-19 Pneumonia, Journal of Isfahan Medical School (2021)
44. A Review of Novel Coronavirus, Severe Acute Respiratory Syndrome Coronavirus 2 (Sars-Cov-2), Iranian Journal of Medical Microbiology (2020)
45. Sars-Cov-2 Vaccines: A Double-Edged Sword Throughout Rapid Evolution of Covid-19, Cell Biology International (2022)
46. Vaccine Production by Recognizing the Functional Mechanisms of Covid-19, Translational Research in Urology (2020)
47. Bioinformatic Screening of Compounds From Iranian Lamiaceae Family Members Against Sars-Cov-2 Spike Protein, Letters in Drug Design and Discovery (2023)
48. Effectiveness of Corticosteroid Therapy in Patients With Moderate to Severe Coronavirus Disease 2019: A Retrospective Study, Journal of Nephropharmacology (2023)
49. Effect of Covid-19 Medications on Corrected Qt Interval and Induction of Torsade De Pointes: Results of a Multicenter National Survey, International Journal of Clinical Practice (2021)
50. The Correlation Between Viral Shedding Duration and Blood Biomarkers in Covid-19-Infected Patients, Journal of Research in Medical Sciences (2022)